KANK1 regulates paclitaxel resistance in lung adenocarcinoma A549 cells

References

• Roth JA, Carlson JJ. Prognostic role of ERCC1 in advanced non-small-cell lung cancer: a systematic review and meta-analysis. Clin Lung Cancer. 2011;12(6):393–401.
   PubMed Web of Science ®Google Scholar
• de Castro J, Rodriguez MC, Martinez-Zorzano VS, et al. Erythrocyte fatty acids as potential biomarkers in the diagnosis of advanced lung adenocarcinoma, lung squamous cell carcinoma, and small cell lung cancer. Am J Clin Pathol. 2014;142:111–120.
   PubMed Web of Science ®Google Scholar
• Herbst RS, Morgensztern D, Boshoff C. The biology and management of non-small cell lung cancer. Nature. 2018;553(7689):446–454.
   PubMed Web of Science ®Google Scholar
• Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.
   PubMed Web of Science ®Google Scholar
• Wu K, Li J, Qi Y, et al. SNHG14 confers gefitinib resistance in non-small cell lung cancer by up-regulating ABCB1 via sponging miR-206-3p. Biomed Pharmacother. 2019;116:108995.
   PubMed Web of Science ®Google Scholar
• Yuan H, Sun B, Gao F, et al. Synergistic anticancer effects of andrographolide and paclitaxel against A549 NSCLC cells. Pharm Biol. 2016;54(11):2629–2635.
   PubMed Web of Science ®Google Scholar
• Orr GA, Verdier-Pinard P, McDaid H, et al. Mechanisms of Paclitaxel resistance related to microtubules. Oncogene. 2003;22(47):7280–7295.
   PubMed Web of Science ®Google Scholar
• Gottesman MM. Mechanisms of cancer drug resistance. Annu Rev Med. 2002;53(1):615–627.
   PubMed Web of Science ®Google Scholar
• Blagosklonny MV, Fojo T. Molecular effects of paclitaxel: myths and reality (a critical review). Int J Cancer. 1999;83(2):151–156.
   PubMed Web of Science ®Google Scholar
• Dumontet C, Sikic BI. Mechanisms of action of and resistance to antitubulin agents: microtubule dynamics, drug transport, and cell death. J Clin Oncol . 1999;17(3):1061–1070.
   PubMed Web of Science ®Google Scholar
• Kelly AD, Issa JJ. The promise of epigenetic therapy: reprogramming the cancer epigenome. Curr Opin Genet Dev. 2017;42:68–77.
   PubMed Web of Science ®Google Scholar
• Bogdanovic O, Lister R. DNA methylation and the preservation of cell identity. Curr Opin Genet Dev. 2017;46:9–14.
   PubMed Web of Science ®Google Scholar
• Portela A, Esteller M. Epigenetic modifications and human disease. Nat Biotechnol. 2010;28(10):1057–1068.
   PubMed Web of Science ®Google Scholar
• Wong KM, Hudson TJ, McPherson JD. Unraveling the genetics of cancer: genome sequencing and beyond. Annu Rev Genom Hum Genet. 2011;12(1):407–430.
   PubMed Web of Science ®Google Scholar
• Toh TB, Lim JJ, Chow EK. Epigenetics in cancer stem cells. Mol Cancer. 2017;16(1):29.
   PubMed Web of Science ®Google Scholar
• Luo FY, Xiao S, Liu ZH, et al. KANK1 reexpression induced by 5-Aza-2′-deoxycytidine suppresses nasopharyngeal carcinoma cell proliferation and promotes apoptosis. Int J Clin Exp Path. 2015;8(2):1658–1665.
   PubMed Web of Science ®Google Scholar
• Catic A, Kurtovic-Kozaric A, Johnson SH, et al. A novel cytogenetic and molecular characterization of renal metanephric adenoma: Identification of partner genes involved in translocation t(9;15)(p24;q24). Cancer Genetics. 2017;214-215:9–15.
   PubMed Web of Science ®Google Scholar
• Chen T, Wang K, Tong X. In vivo and in vitro inhibition of human gastric cancer progress by upregulating KANK1 gene. Oncology Reports. 2017;38(3):1663–1669.
   PubMed Web of Science ®Google Scholar
• Cui Z, Shen Y, Chen KH, et al. KANK1 inhibits cell growth by inducing apoptosis though regulating CXXC5 in human malignant peripheral nerve sheath tumors. Sci Rep. 2017;7(1):40325.
   PubMed Web of Science ®Google Scholar
• Xu Y, Zhang C, Liang H, et al. Dishevelled 1, a pivotal positive regulator of the Wnt signalling pathway, mediates 5-fluorouracil resistance in HepG2 cells. Artif Cells Nanomed Biotechnol. 2018;46(sup2):192–200.
   PubMed Web of Science ®Google Scholar
• Liang H, Xu Y, Zhang Q, et al. MiR-483-3p regulates oxaliplatin resistance by targeting FAM171B in human colorectal cancer cells. Artif Cells Nanomed Biotechnol. 2019;47(1):725–736.
   PubMed Web of Science ®Google Scholar
• Romualdi C, Bortoluzzi S, D’Alessi F, et al. IDEG6: a web tool for detection of differentially expressed genes in multiple tag sampling experiments. Physiolog Genom. 2003;12(2):159–162.
   PubMed Web of Science ®Google Scholar
• Tang Z, Li C, Kang B, et al. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45(W1):W98–W102.
   PubMed Web of Science ®Google Scholar
• Zhang S, Wang Y, Chen M, et al. CXCL12 methylation-mediated epigenetic regulation of gene expression in papillary thyroid carcinoma. Sci Rep. 2017;7(1):44033.
   PubMed Web of Science ®Google Scholar
• Clevers H. Wnt/beta-catenin signaling in development and disease. Cell. 2006;127(3):469–480.
   PubMed Web of Science ®Google Scholar
• Pappa A, Chen C, Koutalos Y, et al. ALDH3A1 protects human corneal epithelial cells from ultraviolet- and 4-hydroxy-2-nonenal-induced oxidative damage. Free Radic Biol Med. 2003;34:1178–1189.
   PubMed Web of Science ®Google Scholar
• Soria JC, Mark Z, Zatloukal P, et al. Randomized phase II study of dulanermin in combination with paclitaxel, carboplatin, and bevacizumab in advanced non-small-cell lung cancer. J Clin Oncol. 2011;29(33):4442–4451.
   PubMed Web of Science ®Google Scholar
• Mayer IA, Arteaga CL. The PI3K/AKT pathway as a target for cancer treatment. Annu Rev Med. 2016;67(1):11–28.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Luo Q, Wang N, et al. LRG1 suppresses the migration and invasion of hepatocellular carcinoma cells. Med Oncol. 2015;32(5):146.
   PubMed Web of Science ®Google Scholar
• Han SJ, Chen R, Paronetto MP, et al. Wee1B is an oocyte-specific kinase involved in the control of meiotic arrest in the mouse. Curr. Biol. 2005;15(18):1670–1676.
   PubMed Web of Science ®Google Scholar
• Suzuki JI, Roy BC, Ogaeri T, et al. Depletion of tumor suppressor KANK1 induces centrosomal amplification via hyperactivation of RhoA. Exp Cell Res. 2017;353(2):79–87.
   PubMed Web of Science ®Google Scholar
• Medves S, Duhoux FP, Ferrant A, et al. KANK1, a candidate tumor suppressor gene, is fused to PDGFRB in an imatinib-responsive myeloid neoplasm with severe thrombocythemia. Leukemia. 2010;24(5):1052–1055.
   PubMed Web of Science ®Google Scholar
• Turner NC, Reis-Filho JS. Genetic heterogeneity and cancer drug resistance. Lancet Oncol. 2012;13(4):e178–185.
   PubMed Web of Science ®Google Scholar
• Wu J, Chen X, Bao Q, et al. Osterix decreases the chemosensitivity of breast cancer cells by upregulating GALNT14. Cell Physiol Biochem. 2017;44(3):998–1010.
   PubMedGoogle Scholar
• Parajuli B, Fishel ML, Hurley TD. Selective ALDH3A1 inhibition by benzimidazole analogues increase mafosfamide sensitivity in cancer cells. J Med Chem. 2014;57(2):449–461.
   PubMed Web of Science ®Google Scholar
• Guo X, Fan W, Bian X, et al. Upregulation of the KANK1 gene-induced brain glioma apoptosis and blockade of the cell cycle in G0/G1 phase. Int J Oncol. 2014;44(3):797–804.
   PubMed Web of Science ®Google Scholar
• Tomiyama A, Tachibana K, Suzuki K, et al. MEK-ERK-dependent multiple caspase activation by mitochondrial proapoptotic Bcl-2 family proteins is essential for heavy ion irradiation-induced glioma cell death. Cell Death Dis. 2010;1:e60.
   PubMed Web of Science ®Google Scholar
• Gu Y, Zhang M. Upregulation of the KANK1 gene inhibits human lung cancer progression in vitro and in vivo. Oncol Rep. 2018;40:1243–1250.
   PubMed Web of Science ®Google Scholar